share_log

TherapeuticsMD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(25.73%),David Rosen(25.73%)

TherapeuticsMD | SC 13D/A:超過5%持股股東披露文件(修正)-Rubric Capital Management LP(25.73%),David Rosen(25.73%)

SEC announcement ·  2023/11/17 09:28
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息